Mary Fisher lands OvaScience board appointment
This article was originally published in Scrip
Executive Summary
Massachusetts-based OvaScience, a life sciences company focused on developing new treatments for infertility, has appointed Mary Fisher to its board of directors. Ms Fisher, who has over 25 years' experience in the pharma and biotech industries, is currently president and CEO of Colorscience, a former division of SkinMedica. Prior to that, she was COO of Acorda Therapeutics. She also serves on the board of the Neuroscience Nursing Foundation.